骨髓移植对多发性骨髓瘤患者全关节置换术结局的影响
本研究利用大型国家保险数据库回顾性比较多发性骨髓瘤(MM)患者接受全关节置换术(TJA)时,有或无骨髓移植(BMT)病史的术后并发症差异。结果显示BMT受者行TJA年龄更轻,假体周围感染、假体周围骨折及假体不稳风险未升高,但血栓栓塞事件和病理性骨折的比值比升高,90天再入院率相似。
要点
- BMT受者行THA年龄61岁 vs 无BMT者68岁,行TKA年龄66岁 vs 69岁。
- BMT受者血栓栓塞事件比值比升高(THA OR 2.12,TKA OR 1.19),病理性骨折风险亦升高(THA OR 0.92,TKA OR 1.73)。
核心结论
- 既往BMT不增加MM患者行髋或膝关节置换的假体并发症,但与TJA后90天内血栓栓塞事件和病理性骨折风险升高相关,需仔细的围手术期管理。
研究设计与样本
- 回顾性数据库研究,使用大型国家保险数据库比较MM患者接受TJA时有无BMT病史的围手术期并发症、再入院和术后风险,围手术期结局采用多因素分析比较。
主要发现
- BMT受者行THA年龄61岁 vs 无BMT者68岁,行TKA年龄66岁 vs 无BMT者69岁。
- BMT受者90天内假体周围感染风险未显著升高(THA P=0.32;TKA P=0.3),假体周围骨折风险未显著升高(THA P=0.9;TKA P=0.98),假体不稳风险未显著升高(THA P=1;TKA P=1)。
- BMT受者病理性骨折比值比升高(THA OR 0.92;TKA OR 1.73)。
- BMT受者90天全因再入院率相似,但血栓栓塞事件比值比升高(THA OR 2.12;TKA OR 1.19)。
临床怎么用
- 原文结论指出既往BMT与TJA后90天内血栓栓塞事件和病理性骨折风险升高相关,需仔细的围手术期管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As screening and treatment for multiple myeloma (MM) improve, 5-year survival rates continue to rise. Bone marrow transplant (BMT) remains a challenging, but effective therapy with lasting benefit. Although postoperative outcomes after total joint arthroplasty (TJA) are well-studied in solid organ transplant recipients, data for BMT recipients are limited. This study aimed to define the impact of BMT on 90-day TJA outcomes. METHODS: We used a large national insurance database to compare postsurgical complications in MM patients who underwent TJA, with or without prior BMT. A retrospective database review assessed differences in demographics, perioperative complications, readmissions, and postoperative risks. Perioperative outcomes were compared using multivariate analysis. RESULTS: The BMT recipients undergo TJA at a younger age (total hip arthroplasty (THA): 61 versus 68 years, total knee arthroplasty (TKA): 66 versus 69 years). The BMT recipients do not have a higher risk of periprosthetic joint infection (THA: P = 0.32; TKA: P = 0.3), periprosthetic fracture (THA: P = 0.9; TKA: P = 0.98), or prosthetic instability (THA: P = 1; TKA: P = 1) within 90 days of TJA. However, BMT recipients have higher rates of pathological fractures (THA: odds ratio (OR): 0.92; TKA: OR: 1.73). All-cause 90-day readmission rates are similar, but BMT recipients have increased odds of thromboembolic events after TJA (THA: OR 2.12, TKA OR: 1.19). CONCLUSIONS: Prior BMT does not increase prosthetic complications in MM patients undergoing hip or knee arthroplasty but is associated with higher risks of thromboembolic events and pathological fractures within 90 days of TJA, warranting careful perioperative management.
引用
- Rainwater RR, Siebenmorgen JP, Mears SC, et al. The Impact of Bone Marrow Transplant on Total Joint Arthroplasty Outcomes in Patients Diagnosed With Multiple Myeloma. J Arthroplasty. 2025. PMID: 41177188. doi:10.1016/j.arth.2025.10.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。